Skip to main content

Human Milk Oligosaccharides Market To Witness Significant Demand From Agriculture Industry Till 2012 - 2024.

The drivers of human milk oligosaccharides market include speedy technological improvements in product line, rise in application in the infant supplements, growing application in food and beverages and increasing use in dairy sector. Moreover, change in lifestyle, rise in health awareness and rising demand for human milk donors are expected to drive the market growth. However, low availability of raw materials and high priced chemical and enzymatic synthesis techniques, lack of technical expertise and significant R&D cost are hampering the market growth. Nevertheless, leading players adopting merger& acquisition, affiliations and collaboration strategy and improvements in supply chain management are a few trends in human milk oligosaccharides industry. Moreover, future investments are expected to bring opportunities for the market players.

Download Free Sample  - https://www.millioninsights.com/industry-reports/human-milk-oligosaccharides-hmo-market/request-sample

Human milk oligosaccharides market is categorized on the basis of type, application and geography. On the basis of type, the market is divided into LNT &LNnT, sialyllactose and fucosyllactose. Fucosyllactose segment is predicted to hold larger market share due to rising use in infant supplements. Based on application, HMO industry is divided into food & beverages, health ingredients for human & animal, infant formulas and food supplements. Infant supplement segment leads the HMO market due to the increasing number of child malnourishment cases and growth in mortality.

Geographically, human milk oligosaccharides industry is segmented as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America followed by Europe are erected to dominate the market of human milk oligosaccharides due to increasing number of manufacturers and rise in demand for infant formulas in Italy, France, Spain and U.K. Europe and Asia Pacific are also projected to lead in future due to increasing demand for nutritional food products. The prominent players in human milk oligosaccharides (HMO) industry include Abbott, Dextra Laboratories, Inbiose, Jennewein Biotechnologie GmbH, Glycosyn LLC, Glycom A/S, ZuChem, Inc., Elicityl SA and Medolac Laboratories.

Comments

Popular posts from this blog

Functional Tea Market is expected to boost the growth of the market over the forecast period.

Functional Tea refers to a series of teas that can contribute to bodily functions. In 2019, the market size of Functional Tea is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Download Request sample copy -  https://www.innovationmarketresearch.com/market-reports/functional-tea-market/request-sample In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Functional Tea. This report studies the global market size of Functional Tea, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Functional Tea sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sal...

Atherectomy Devices Industry Landscape & Scope Till, 2014 - 2025.

Asia pacific can be a potential market for atherectomy devices since countries such as India and china possess the largest number of cardiac patients with an annual incidence of 7 million strokes. Tobacco consumption is rapidly increasing in south Asian countries in conjunction with economic expansion increasing their risk of artery diseases. Reduction of abdominal obesity through lifestyle measures can improve all components of the metabolic syndrome and likely delay the development of both diabetes and atherosclerosis. Beyond lifestyle intervention, optimal management of risk factors to evidence-based targets is essential. Download Free Sample -  https://www.millioninsights.com/industry-reports/atherectomy-devices-market-size/request-sample High awareness of health problems caused due to change in lifestyle and optimal management of risk factors can improve the metabolic syndrome and likely reduce the development of both diabetes and atherosclerosis and hence reducing the de...

What are the land and construction requirements to start an Adipic Acid (CAS 124-04-9) manufacturing plant?

  Adipic acid or hexanedioic acid is the most important dicarboxylic acid with the formula (CH2)4(COOH)2. It is produced industrially by the oxidation of cyclohexanone and cyclohexanol with nitric acid. Adipic acid is one of the most important monomers, predominantly as a precursor for the production of nylon 66. The analysts forecast the global adipic acid market to exhibit a CAGR of 4.2% during the period 2019-2024. The report covers the present scenario and the growth prospects of the global adipic acid for 2019-2024. To calculate the market size, the report considers the adipic acid sales volume and revenue. Download Free Sample  -  https://www.radiantinsights.com/research/adipic-acid-cas-124-04-9-market/request-sample The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to...